4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-024928
Director sold 8,000 shares at an average $18.38 ($147,010)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-04-15 | Option exercise | −8,000 | $9.24 | $73,920 | 284,973 | D |
| CHESS ROBERT Director | 2020-04-15 | Sale | −7,803 | $18.36 | $143,263 | 277,170 | D |
| CHESS ROBERT Director | 2020-04-15 | Sale | −197 | $19.02 | $3,747 | 276,973 | D |
| Derivatives | |||||||
| CHESS ROBERT Director | 2020-04-15 | Option exercise · Stock Option | −8,000 | 16,000 | D | ||
| Open-market sales · 8,000 sh · avg $18.38 · $147,010 | |||||||
Loading xslF345X03/doc4.xml…